ECSP003725A - METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) -5- CETO-2-N, N-D1-N-PROPILAMINO-TETRAHIDROTETRALINA - Google Patents

METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) -5- CETO-2-N, N-D1-N-PROPILAMINO-TETRAHIDROTETRALINA

Info

Publication number
ECSP003725A
ECSP003725A ECSP003725A ECSP003725A EC SP003725 A ECSP003725 A EC SP003725A EC SP003725 A ECSP003725 A EC SP003725A EC SP003725 A ECSP003725 A EC SP003725A
Authority
EC
Ecuador
Prior art keywords
tetrahidrotetralina
propilamino
ceto
evil
administration
Prior art date
Application number
Other languages
Spanish (es)
Inventor
David Juergen Wustrow
Lawrence David Wise
Durk Dijkstra
Leonard Theodore Meltzer
Bastiaan Johan Venhuis
Hakan Vilhelm Wikstrom
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003725 priority Critical patent/ECSP003725A/en
Publication of ECSP003725A publication Critical patent/ECSP003725A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El mal de Parkinson se trata con un compuesto de la fórmula (gráfico), o una sal farmacéuticamente aceptables del mismo.Parkinson's disease is treated with a compound of the formula (graph), or a pharmaceutically acceptable salt thereof.

ECSP003725 2000-10-19 2000-10-19 METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) -5- CETO-2-N, N-D1-N-PROPILAMINO-TETRAHIDROTETRALINA ECSP003725A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003725 ECSP003725A (en) 2000-10-19 2000-10-19 METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) -5- CETO-2-N, N-D1-N-PROPILAMINO-TETRAHIDROTETRALINA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003725 ECSP003725A (en) 2000-10-19 2000-10-19 METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) -5- CETO-2-N, N-D1-N-PROPILAMINO-TETRAHIDROTETRALINA

Publications (1)

Publication Number Publication Date
ECSP003725A true ECSP003725A (en) 2001-04-23

Family

ID=42041304

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003725 ECSP003725A (en) 2000-10-19 2000-10-19 METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) -5- CETO-2-N, N-D1-N-PROPILAMINO-TETRAHIDROTETRALINA

Country Status (1)

Country Link
EC (1) ECSP003725A (en)

Similar Documents

Publication Publication Date Title
NO2012015I2 (en) Dapoxetine
ECSP044992A (en) INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4
LU91928I2 (en) Ipilimumab and its pharmaceutically acceptable derivatives (YERVOY®)
GB0318447D0 (en) Therapeutic agents
GB0225475D0 (en) Therapeutic agents
BR0316753A (en) Treatment method for sexual dysfunction
EA200300527A1 (en) NEW TREATMENT METHODS FOR TIRED FOOT SYNDROME
BR0109703A (en) Piperazine Derivatives
HRP20090281T1 (en) 1,2,3,4-TETRASUBSTITUATED INDOL FOR TREATMENT OF RESPIRATORY DISEASES
EA200801805A1 (en) HIGH-SELECTIVE INHIBITORS OF REVERSE CAPTURE OF NOREPINEFRIN AND METHODS OF THEIR APPLICATION
EA200300544A1 (en) EFFECTIVE ANTI-TUMOR MEDICINE
MX9305248A (en) DIARILPIPERAZINOACETAMIDA COMPOUNDS.
BR0107628A (en) 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation
DK1458393T3 (en) Substituted diketopiperazines as oxytocin antagonists
AR036137A1 (en) NEW SALTS OF ANTI-CONVULSIVE DERIVATIVES
AP2002002387A0 (en) Method of inhibiting amyloid aggregation and imaging amyloid deposits.
DK1305037T3 (en) Painkiller
SE0101082D0 (en) Novel use
EE200300129A (en) Use of distamycin alpha-haloacryloyl derivative
ECSP014079A (en) SULFONAMIDE DERIVATIVES
AR035406A1 (en) ELETRIPTAN PREPARATION PROCEDURE
ECSP003725A (en) METHOD FOR TREATING PARKINSON EVIL THROUGH THE ADMINISTRATION OF (-) -5- CETO-2-N, N-D1-N-PROPILAMINO-TETRAHIDROTETRALINA
ECSP014078A (en) SULFONAMIDE DERIVATIVES
UY26405A1 (en) METHOD FOR TREATING PARKINSON'S EVIL THROUGH THE ADMINISTRATION OF (-) - 5-CETO-2-N, N-D1-N-PROPYLAMINE-TETRAHYDROTETRALINE.
SE0004827D0 (en) Therapeutic compounds